Loading...
Loading...

At UK Pathology Limited, our mission is to deliver precise and timely pathology reporting through innovative remote telepathology services and expert consultations. We are dedicated to bridging the gap between the NHS and private sector, fostering collaboration and excellence in histopathology practices. Our commitment to education and advisory services empowers private hospitals, research institutes, and start-up companies to achieve the highest standards in pathology.

We offer precise interpretation of breast and renal (native and transplant) cases to NHS Trusts, commercial healthcare partners, telepathology companies, and research institutions worldwide.

We have state of the art facilities for reporting both glass slides and digital images. Our comprehensive written histopathology reports include the Royal College of Pathologists’ standard minimum dataset.  Reports can be customised to comply with local reporting policies.

I have been involved in implementing digital pathology for my department as a lead in that field. During my attendance at various digital conferences I came to realise how rapidly the technology is progressing, especially in the development of artificial intelligent software for medical use.

I will give advice to software companies from a pathologist perspective and assist in development of software. This can be just a consultation, evaluation and feedback of software and/or providing technical support as a pathologist.

“I am very happy to endorse Dr Mohammad Khan as a breast Consultant Histopathologist. I have worked with Dr Khan for 5 years and have consistently rated his histopathology reports. The reports are clear, concise and issued in a timely manner. Dr Khan is also very approachable and never minds me ringing up to speak to him about individual cases.

I have always impressed with his precise descriptions of pathology when we are in our multidisciplinary team meeting and he always manages to simplify complex reports so that everyone in the room understands the nuances of breast disease.”

Mrs Michelle Mullan, Consultant Oncoplastic Breast Surgeon and Lead Breast Surgeon for North Bristol NHS Trust

“Dr. Mo Khan has been an invaluable asset to Axon Diagnostics, playing a key role supporting us in establishing our innovative pathology platform and reporting services division. His expertise and vision have allowed us to develop something that’s set new standards for accuracy, efficiency, and innovation within pathology diagnosis. Dr. Khan’s insights were invaluable in educating both our commercial team and executive board on the clinical aspects of our services, aligning our efforts with our core value of patient-first care.

Under Dr. Khan’s guidance, we have implemented cutting-edge pathology services that are now a cornerstone of our operations. His commitment to excellence and passion for advancing medical diagnostics are inspiring. We are grateful for his contributions and look forward to continuing our collaboration.”

Rahul Mehta, Director, Axon Diagnostics

“Dr Khan is an outstanding consultant histopathologist with extensive experience in both the NHS and the commercial sector. He expertly bridges the gap between clinical excellence and business efficiency, he has been a valuable advisor to our Health Now Service and has been able to contribute to our discussions around staffing shortages and increasing demand. Dr Khan leverages digital solutions to enhance service delivery and combined with his extensive clinical expertise he is able to ensure top-tier histopathology services for clinicians and patients alike.

We look forward to continuing to work with Dr Khan as a consultant and advisor to Health Now.”

Justine Sudbury, Associate Director, Health Now